Interview with Joel Morse, Curavit CEO
Joel Morse has devoted his career to building innovative companies that serve the pharmaceutical industry. His latest venture, Curavit Clinical Research runs decentralized or virtual trials, which have grown dramatically in the pandemic. I’m a big fan --and will be a panelist on a Curavit-sponsored webinar: Are You Ready to Go Virtual? Unlocking the Full Potential of Decentralized Clinical Trials. The webinar is on March 11 at 1 pm EST. Register here.In this episode of the HealthBiz podcast, Joel talks about decentralized trials and why they’re growing. He also opens up about his experience building C3i, and how it led him to adventures around the world, including Joel’s involvement with the royal family in Bulgaria.Check out the rough (AI generated) transcript.The HealthBiz podcast is available on Spotify, Apple Podcasts, Google Podcasts and many more services. Please consider rating the podcast on Apple Podcasts. Doing so helps the podcast reach more listeners.
By healthcare business consultant David E. Williams, president of Health Business Group.